Originally founded by two faculty from North Carolina State University (NCSU) to provide commercial solutions to those industries plagued by the effects of biofilms, Agile Sciences has developed compounds that can disperse the offending colonies of bacteria: capabilities relevant to the fields of human medicine, agriculture, and industry. Agile Sciences is focused particularly on exploiting the attributes of the compounds developed by the firm in three speciific therapeutic areas that are difficult-to-treat: 1) Multidrug-resistant bacterial infections 2) Lung infections in cystic fibrosis patients 3) Chronic wound infectionsBiofilms that form in the human body are up to ten thousand times more resistant to antibiotics and immune systems than free-floating bacteria, making them very difficult to treat medically.